Skip to content
  • About
    • Mission & Values
    • Expertise
    • Team
    • Responsibility
    • Careers
    • Contact Us
  • Portfolio
    • Strategy
    • Current Products
    • Legacy Products
    • Partners in Innovation
  • Investors
    • Overview
    • Stock Quotes
    • News & Events
    • Presentations
    • Financials
    • Analyst Coverage
    • Investor FAQ
    • ESG
    • Tax Information
  • About
    • Mission & Values
    • Expertise
    • Team
    • Responsibility
    • Careers
    • Contact Us
  • Portfolio
    • Strategy
    • Current Products
    • Legacy Products
    • Partners in Innovation
  • Investors
    • Overview
    • Stock Quotes
    • News & Events
    • Presentations
    • Financials
    • Analyst Coverage
    • Investor FAQ
    • ESG
    • Tax Information

Archives: News Releases

DRI Healthcare Trust to Host Fourth Quarter and Full Year 2022 Earnings Call and Webcast on March 2, 2023

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today that it will hold a conference call to discuss its fourth quarter and full year 2022 financial results on…

DRI Healthcare Trust Announces US$95 million Private Placement of Preferred Securities and Increased Deployment Target

Provides additional capital to fund biopharmaceutical research, driving value for DRI’s unitholders and partners TORONTO, Feb. 8, 2023 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U)…

DRI Healthcare Trust Declares Unit Distribution and Provides Update on Normal Course Issuer Bid

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that, in accordance with the requirement for the Trust to distribute all of its taxable income for the year,…

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of Xenpozyme® (olipudase alfa) for the Treatment of Acid Sphingomyelinase Deficiency

– Transaction adds another innovative rare disease therapy to DRI’s expanding portfolio – – Deal structure offers risk sharing with milestone payments for positive performance – –…

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of Xenpozyme® (olipudase alfa) for the Treatment of Acid Sphingomyelinase Deficiency

– Transaction adds another innovative rare disease therapy to DRI’s expanding portfolio – – Deal structure offers risk sharing with milestone payments for positive performance – –…

DRI Healthcare Trust Reports Third Quarter 2022 Results

– Transactions for Empaveli, Zejula and Omidria royalties mark significant progress – – Cash receipts expected to be flat to slightly increasing through 2025 even with no further deployment – -…

DRI Healthcare Trust Announces Appointment of Poonam Puri to Board of Trustees

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced Poonam Puri has been appointed as an independent member of the Trust’s board of trustees effective…

DRI Healthcare Trust Reports Third Quarter 2022 Results

– Transactions for Empaveli, Zejula and Omidria royalties mark significant progress – – Cash receipts expected to be flat to slightly increasing through 2025 even with no further deployment – -…

DRI Healthcare Trust Announces Appointment of Poonam Puri to Board of Trustees

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced Poonam Puri has been appointed as an independent member of the Trust’s board of trustees effective…

DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 8, 2022

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today it will hold a conference call to discuss its third quarter 2022 financial results on Tuesday, November 8,…

← Previous
Next →

Offices:

  • Toronto
    100 King St. West, Suite 7250
    Toronto, ON M5X 1B1
  • New Jersey
    101 JFK Parkway, 3rd floor Suite 3
    Short Hills, NJ 07078
  • 416-863-1865
  • info@drihealthcare.com
  • linkedin.com/company/dri-healthcare/

Investor Relations:

  • 416-324-5738
  • ir@drihealthcare.com
  • About
    • Mission & Values
    • Expertise
    • Team
    • Responsibility
    • Careers
    • Contact Us
  • Portfolio
    • Strategy
    • Current Products
    • Legacy Products
    • Partners in Innovation
  • Investors
    • Overview
    • Stock Quotes
    • News & Events
    • Presentations
    • Financials
    • Analyst Coverage
    • Investor FAQ
    • ESG
    • Tax Information
  • About
    • Mission & Values
    • Expertise
    • Team
    • Responsibility
    • Careers
    • Contact Us
  • Portfolio
    • Strategy
    • Current Products
    • Legacy Products
    • Partners in Innovation
  • Investors
    • Overview
    • Stock Quotes
    • News & Events
    • Presentations
    • Financials
    • Analyst Coverage
    • Investor FAQ
    • ESG
    • Tax Information

© 2025 DRI Healthcare. All Rights Reserved

  • Privacy Policy
  • Terms of Use
  • Whistleblower Information
  • Privacy Policy
  • Terms of Use
  • Whistleblower Information